Abstract | OBJECTIVES: This study aimed to compare the efficacy and safety of the Nit-Occlud PDA device (PFM Medical, Cologne, Germany) to benchmarks designed as objective performance criteria (OPC). BACKGROUND: The Nit-Occlud PDA is a nitinol coil-type patent ductus arteriosus (PDA) occluder with a reverse cone configuration, which is implanted using a controlled delivery system. METHODS: Patients with <4-mm minimum diameter PDA were prospectively enrolled in the Pivotal and the Continuing Access Studies from 15 sites in the United States and were followed up for 12 months post-procedure. Investigator-reported outcomes were compared to OPC including a composite success criterion, efficacy criteria of successful closure (clinical and echocardiographic), and safety criteria incidence of adverse events (serious and of total). RESULTS: The Pivotal Study enrolled patients between November 1, 2002 and October 31, 2005, and the Continuing Access Study enrolled additional patients between September 1, 2006 and October 31, 2007. A total of 357 patients were enrolled, and 347 had successful device implantations. After 12 months, 96.8% had complete echocardiographic closure (OPC = 85%) and 98.1% had clinical closure (OPC = 95%). There were no deaths or serious adverse events (OPC = 1%). The total adverse event rate was 4.7% (OPC = 6%). Composite success was 95.1% in the study patients (OPC = 80%). CONCLUSIONS: Closure of small- and medium-sized PDA with the Nit-Occlud PDA is effective and safe when compared with OPC.
|
Authors | John W Moore, Jessica Greene, Salvadore Palomares, Alexander Javois, Carl Y Owada, John P Cheatham, Mark H Hoyer, Thomas K Jones, Daniel S Levi, Pivotal and Continuing Access Studies of the Nit Occlud PDA Investigators |
Journal | JACC. Cardiovascular interventions
(JACC Cardiovasc Interv)
Vol. 7
Issue 12
Pg. 1430-6
(Dec 2014)
ISSN: 1876-7605 [Electronic] United States |
PMID | 25523534
(Publication Type: Clinical Trial, Journal Article, Multicenter Study)
|
Copyright | Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Adolescent
- Alloys
- Cardiac Catheterization
(adverse effects, instrumentation)
- Child
- Child, Preschool
- Ductus Arteriosus, Patent
(diagnosis, therapy)
- Female
- Humans
- Infant
- Male
- Prospective Studies
- Prosthesis Design
- Risk Factors
- Time Factors
- Treatment Outcome
- United States
- Young Adult
|